These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22890830)

  • 1. Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.
    Zhang W; Guo N; Yu C; Wang H; Zhang Y; Xia H; Yu J; Lu J
    Tumour Biol; 2012 Dec; 33(6):2209-16. PubMed ID: 22890830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differential expressions of MDR-1, RRM-1, EGFR and ERCC-1 in primary tumors and metastatic lymph nodes of NSCLC patients].
    Guo N; Li S; Zhang W; Yu C; Wang H; Zhang Y; Yu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):870-3. PubMed ID: 23948418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the expression profiles of excision repair crosscomplementation group 1, x-ray repair crosscomplementation group 1, and betaIII-tubulin between primary non-small cell lung cancer and metastatic lymph nodes and the significance in mid-term survival.
    Kang CH; Jang BG; Kim DW; Chung DH; Kim YT; Jheon S; Sung SW; Kim JH
    J Thorac Oncol; 2009 Nov; 4(11):1307-12. PubMed ID: 19745766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of annexin II expression in non-small cell lung cancer.
    Luo CH; Liu QQ; Zhang PF; Li MY; Chen ZC; Liu YF
    Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
    Zhang Y; Ma M; Han B
    Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites.
    Gomez-Roca C; Raynaud CM; Penault-Llorca F; Mercier O; Commo F; Morat L; Sabatier L; Dartevelle P; Taranchon E; Besse B; Validire P; Italiano A; Soria JC
    J Thorac Oncol; 2009 Oct; 4(10):1212-20. PubMed ID: 19687761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.
    Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL
    Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study.
    Li H; Zhou RJ; Zhang GQ; Xu JP
    Tumour Biol; 2013 Jun; 34(3):1807-12. PubMed ID: 23471668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer.
    Lin G; Sun L; Wang R; Guo Y; Xie C
    J Thorac Oncol; 2014 Feb; 9(2):170-8. PubMed ID: 24419413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
    Ozdemir O; Ozdemir P; Veral A; Uluer H; Ozhan MH
    Asian Pac J Cancer Prev; 2013; 14(8):4679-83. PubMed ID: 24083725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
    Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1 protein expression in non-small cell lung cancers is correlated with prognosis.
    Huang AL; Liu SG; Qi WJ; Zhao YF; Li YM; Lei B; Sheng WJ; Shen H
    Asian Pac J Cancer Prev; 2014; 15(19):8143-7. PubMed ID: 25338997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p114RhoGEF predicts lymph node metastasis and poor survival of squamous-cell lung carcinoma patients.
    Song C; Gao Y; Tian Y; Han X; Chen Y; Tian DL
    Tumour Biol; 2013 Jun; 34(3):1925-33. PubMed ID: 23512329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy.
    Xie KJ; He HE; Sun AJ; Liu XB; Sun LP; Dong XJ
    Asian Pac J Cancer Prev; 2014; 15(6):2591-6. PubMed ID: 24761869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.
    Wang X; Du Z; Li L; Shi M; Yu Y
    Int J Clin Exp Pathol; 2015; 8(9):10644-52. PubMed ID: 26617774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke.
    Liu X; Liu B; Cui Y; Wang F; Sun H; Lv F
    Tumour Biol; 2014 Nov; 35(11):11677-83. PubMed ID: 25139095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Molecular Markers in Primary Sites and Metastatic Lymph Nodes of Lung Cancer Patients.
    Li J; Zhang W; Guo N; Yu J; Zhao Y; Li S
    Med Sci Monit; 2017 Jan; 23():513-520. PubMed ID: 28130961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer.
    Vázquez PF; Carlini MJ; Daroqui MC; Colombo L; Dalurzo ML; Smith DE; Grasselli J; Pallotta MG; Ehrlich M; Bal de Kier Joffé ED; Puricelli L
    Clin Exp Metastasis; 2013 Dec; 30(8):993-1007. PubMed ID: 23832740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.